Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHCO
3026
DELISTED
Soho House & Co
SHCO
| $368K | ﹤0.01% |
+56,300
| New | +$334K |
|
3027
Verrica Pharmaceuticals
VRCA
$89.7M
| $367K | ﹤0.01% |
5,650
-9,987
| -64% | -$604K |
|
|
EMX
3028
DELISTED
EMX Royalty
EMX
| $366K | ﹤0.01% |
184,159
+96,440
| +110% | +$191K |
|
3029
JPMorgan Chase
JPM
$935B
| $366K | ﹤0.01% |
+2,809
| New | +$385K |
|
3030
Sportradar
SRAD
$4.3B
| $366K | ﹤0.01% |
31,500
+18,700
| +146% | +$217K |
|
|
TOUR
3031
Tuniu
TOUR
$53.9M
| $365K | ﹤0.01% |
19,523
-5,250
| -21% | -$105K |
|
|
WIMI
3032
WiMi Hologram Cloud
WIMI
$22.1M
| $364K | ﹤0.01% |
33,730
-4,090
| -11% | -$49.8K |
|
|
ACHL
3033
DELISTED
Achilles Therapeutics
ACHL
| $364K | ﹤0.01% |
380,233
-104,500
| -22% | -$113K |
|
3034
iShares MSCI Taiwan ETF
EWT
$9.86B
| $363K | ﹤0.01% |
+8,000
| New | +$354K |
|
|
LSEA
3035
DELISTED
Landsea Homes
LSEA
| $362K | ﹤0.01% |
59,700
+4,000
| +7% | +$25.6K |
|
3036
Milestone Pharmaceuticals
MIST
$138M
| $362K | ﹤0.01% |
91,800
+24,600
| +37% | +$89.9K |
|
3037
NextCure
NXTC
$16.8M
| $362K | ﹤0.01% |
20,375
-13,507
| -40% | -$260K |
|
3038
Red River Bancshares
RRBI
$662M
| $361K | ﹤0.01% |
7,500
-3,728
| -33% | -$185K |
|
|
COE
3039
51Talk Online Education Group
COE
$106M
| $360K | ﹤0.01% |
52,575
-9,000
| -15% | -$53.7K |
|
3040
Cricut
CRCT
$984M
| $359K | ﹤0.01% |
35,200
-14,900
| -30% | -$144K |
|
|
RAIN
3041
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $359K | ﹤0.01% |
41,100
-9,000
| -18% | -$83.2K |
|
3042
Hagerty
HGTY
$1.17B
| $358K | ﹤0.01% |
40,942
+15,642
| +62% | +$143K |
|
3043
First Western Financial
MYFW
$304M
| $358K | ﹤0.01% |
18,100
-1,200
| -6% | -$29.7K |
|
3044
Quince Therapeutics
QNCX
$22.9M
| $358K | ﹤0.01% |
1,149
+378
| +49% | +$74K |
|
3045
Direct Digital Holdings
DRCT
$1.89M
| $357K | ﹤0.01% |
501
+310
| +162% | +$287K |
|
|
JBIO
3046
Jade Biosciences
JBIO
$1.2B
| $355K | ﹤0.01% |
503
-14
| -3% | -$11.6K |
|
3047
Sonida Senior Living
SNDA
$1.91B
| $355K | ﹤0.01% |
52,291
-500
| -0.9% | -$6.28K |
|
3048
VanEck Morningstar Wide Moat ETF
MOAT
$11.9B
| $354K | ﹤0.01% |
4,800
-3,600
| -43% | -$256K |
|
3049
Vanguard Energy ETF
VDE
$10.1B
| $354K | ﹤0.01% |
3,100
-200
| -6% | -$23.7K |
|
|
SPRB
3050
Spruce Biosciences
SPRB
$118M
| $354K | ﹤0.01% |
2,135
+289
| +16% | +$53.7K |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.